荣昌生物携手梅斯医学锚定医药数字化合作新坐标

荣昌生物2025-06-27

REMEGEN6月26日，荣昌生物与梅斯医学在荣昌生物医药园举行战略合作对接会。荣昌集团总裁王荔强，梅斯医学CEO王帅等出席活动。王荔强在会谈中指出：“当前医药产业正处于数字化转型的关键阶段，梅斯医学在医学数字化领域的专业积累，与荣昌生物‘以临床价值为核心、打造国际化创新药企’的战略定位高度契合。此次合作不仅加速推动具体项目的落地实施，更有助于医药学术生态的系统性革新。我们期待通过创新药与数字医疗...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2546934797?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-06-27 15:55","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2546934797","market":"sh","top_or_hot":-1,"title":"荣昌生物携手梅斯医学 锚定医药数字化合作新坐标","media":"荣昌生物","content":"<div>\n<p>REMEGEN6月26日，荣昌生物与梅斯医学在荣昌生物医药园举行战略合作对接会。荣昌集团总裁王荔强，梅斯医学CEO王帅等出席活动。王荔强在会谈中指出：“当前医药产业正处于数字化转型的关键阶段，梅斯医学在医学数字化领域的专业积累，与荣昌生物‘以临床价值为核心、打造国际化创新药企’的战略定位高度契合。此次合作不仅加速推动具体项目的落地实施，更有助于医药学术生态的系统性革新。我们期待通过创新药与数字医疗...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627160003a4c0a29f&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>荣昌生物携手梅斯医学 锚定医药数字化合作新坐标</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n荣昌生物携手梅斯医学 锚定医药数字化合作新坐标\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-06-27 15:55 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627160003a4c0a29f&s=b><strong>荣昌生物</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>REMEGEN6月26日，荣昌生物与梅斯医学在荣昌生物医药园举行战略合作对接会。荣昌集团总裁王荔强，梅斯医学CEO王帅等出席活动。王荔强在会谈中指出：“当前医药产业正处于数字化转型的关键阶段，梅斯医学在医学数字化领域的专业积累，与荣昌生物‘以临床价值为核心、打造国际化创新药企’的战略定位高度契合。此次合作不仅加速推动具体项目的落地实施，更有助于医药学术生态的系统性革新。我们期待通过创新药与数字医疗...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627160003a4c0a29f&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0256","symbol_name":"金属制品","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627160003a4c0a29f&s=b","article_id":"2546934797","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627160003a4c0a29f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2546934797","pubTimestamp":1751010940,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"REMEGEN6月26日，荣昌生物与梅斯医学在荣昌生物医药园举行战略合作对接会。荣昌集团总裁王荔强，梅斯医学CEO王帅等出席活动。王帅表示，荣昌生物是中国创新药领域的标杆企业，在全球创新药研发赛道表现强劲。对接会上，梅斯医学团队详细介绍了既往合作成果及实践案例。荣昌生物营销中心、医学部及合规部等部门参与研讨，双方就具体项目落地达成共识。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159938":"医药","603040":"新坐标","688331":"荣昌生物","BK0256":"金属制品","BK0264":"汽车制造","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","LU1064130708.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"I\" (USD) ACC","LU2148510915.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"R\" (USD) ACC","BK0239":"医药制造","LU1064131003.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"A\" (USD) ACC","09995":"荣昌生物"},"translate_title":"Rongchang Biotech joins hands with Metz Medical to anchor new coordinates for pharmaceutical digital cooperation","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159938":1,"603040":1,"688331":1,"09995":0.9},"content_text":"REMEGEN6月26日，荣昌生物与梅斯医学在荣昌生物医药园举行战略合作对接会。荣昌集团总裁王荔强，梅斯医学CEO王帅等出席活动。王荔强在会谈中指出：“当前医药产业正处于数字化转型的关键阶段，梅斯医学在医学数字化领域的专业积累，与荣昌生物‘以临床价值为核心、打造国际化创新药企’的战略定位高度契合。此次合作不仅加速推动具体项目的落地实施，更有助于医药学术生态的系统性革新。我们期待通过创新药与数字医疗的深度融合，在提升药品可及性的同时，为中国医药产业探索出一条创新驱动、数字赋能的高质量发展之路。”王帅表示，荣昌生物是中国创新药领域的标杆企业，在全球创新药研发赛道表现强劲。梅斯医学作为医学数字化领域的先锋，将充分发挥“医学+数字化”双驱动优势，全方位助力荣昌生物完善产品全生命周期管理，加速创新成果向临床价值高效转化，携手为患者带来更优治疗方案，推动中国医药产业创新升级。对接会上，梅斯医学团队详细介绍了既往合作成果及实践案例。荣昌生物营销中心、医学部及合规部等部门参与研讨，双方就具体项目落地达成共识。王荔强与王帅代表双方共同签署了战略合作意向书。会前，王帅一行参观了烟台国际生物药谷展示中心和业达孵化大楼创新研发实验室。文字 | 璐馨影像 | 韩硕编辑 | 春媛","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2546934797","isCrawlerRequest":true}

荣昌生物携手梅斯医学 锚定医药数字化合作新坐标

精彩评论

荣昌生物携手梅斯医学锚定医药数字化合作新坐标